Fulgent Genetics CFO has 2,087 shares withheld

Fulgent Genetics’ CFO had shares withheld to cover taxes on vested RSUs, leaving a substantial remaining holding.

Rhea-AI Filing Summary

Fulgent Genetics, Inc. (FLGT) reported that its CFO and Treasurer, Paul Kim, had 2,087 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on February 25, 2025. After this tax-withholding disposition, Kim directly holds 356,543 shares of Fulgent Genetics common stock.

Insider Trade Summary

Tax Withholding: 2,087 shares

Tax Withholding 1 txn

Insider Kim Paul

Role CFO and Treasurer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	2,087	$19.59	$41K

Holdings After Transaction: Common Stock — 356,543 shares (Direct)

Footnotes (1)

1. F1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.

Key Figures

Shares withheld for tax: 2,087 shares Reported value per share: $19.59 per share Shares held after transaction: 356,543 shares +2 more

5 metrics

Shares withheld for tax 2,087 shares Common stock withheld on September 1, 2026 to satisfy tax withholding obligations

Reported value per share $19.59 per share Valuation used for the 2,087 shares withheld for tax on September 1, 2026

Shares held after transaction 356,543 shares Directly owned by CFO and Treasurer Paul Kim after the September 1, 2026 transaction

RSU grant date February 25, 2025 Grant date of restricted stock units whose vesting triggered the tax withholding

Code F transaction shares 2,087 shares Shares disposed of through tax withholding reported under transaction code F

Key Terms

restricted stock units, tax withholding obligations, payment of tax liability by delivering or withholding securities

3 terms

restricted stock units financial

"upon the vesting of certain restricted stock units granted to the reporting person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld from the reporting person to satisfy the tax withholding obligations"

payment of tax liability by delivering or withholding securities financial

"transaction reported as payment of tax liability by delivering or withholding securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FLGT disclose for CFO Paul Kim?

Fulgent Genetics disclosed that CFO Paul Kim had 2,087 common shares withheld on September 1, 2026 to satisfy tax withholding obligations from the vesting of previously granted restricted stock units.

How many FLGT shares does CFO Paul Kim hold after this transaction?

After the September 1, 2026 tax-withholding transaction, CFO Paul Kim directly holds 356,543 shares of Fulgent Genetics common stock, as reported in the Form 4 filing.

Was the FLGT insider transaction a market sale or tax withholding?

The transaction was reported as a payment of tax liability by delivering or withholding securities, not an open-market sale. Shares were withheld upon vesting of restricted stock units granted on February 25, 2025.

What price per FLGT share is associated with the withheld shares?

The 2,087 withheld shares were valued at a reported $19.59 per share in the Form 4, in connection with satisfying tax withholding obligations on vested restricted stock units.

Were the FLGT insider transactions made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed for this Form 4, and no footnote states that the September 1, 2026 transaction was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 07:48 PM EDT Accepted by SEC EDGAR 09/03/2026 - 07:48 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Paul

(Last) (First) (Middle)

C/O FULGENT GENETICS, INC.

4399 SANTA ANITA AVENUE

(Street)

EL MONTE CALIFORNIA 91731

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO and Treasurer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		F		2,087(1)	D	$19.59	356,543	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.

	/s/ Paul Kim	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)